CLW insider plans sale of 8,889 shares valued at $161K

A holder of CLW common stock has filed a Form 144 notice to sell 8,889 shares through Fidelity Brokerage Services LLC on the NYSE, with an indicated aggregate market value of 161,253.35.

Rhea-AI Filing Summary

A holder of CLW common stock has filed a Form 144 notice to sell 8,889 shares through Fidelity Brokerage Services LLC on the NYSE, with an indicated aggregate market value of 161,253.35. The filing states that 16,038,337 shares of this class of common stock are outstanding.

The shares to be sold were acquired as restricted stock vesting compensation from the issuer on several dates, including 490 shares on 10/01/2021, 1,622 shares on 02/28/2023, 3,313 shares on 03/03/2023, 2,305 shares on 03/04/2024, and 1,159 shares on 03/15/2024, each described as compensation.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many CLW common shares are planned to be sold in this Form 144?

The notice covers the proposed sale of 8,889 shares of CLW common stock.

What is the aggregate market value of the CLW shares in the planned sale?

The filing lists an aggregate market value of 161,253.35 for the 8,889 CLW shares to be sold.

On which exchange and through which broker will the CLW shares be sold?

The planned sale is to be executed on the NYSE through Fidelity Brokerage Services LLC, based on the information provided.

How many CLW common shares are reported as outstanding in this notice?

The notice states that there are 16,038,337 CLW common shares outstanding.

How were the CLW shares in this Form 144 acquired?

The shares were acquired through restricted stock vesting from the issuer as compensation on multiple dates between 10/01/2021 and 03/15/2024.

What specific CLW restricted stock vesting amounts are listed?

The filing lists vesting events of 490, 1,622, 3,313, 2,305, and 1,159 CLW common shares, each categorized as compensation.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/28/2025 - 01:24 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001754874
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Clearwater Paper Corp
SEC File Number	001-34146
Address of Issuer	601 WEST RIVERSIDE AVENUE SUITE 1100 SPOKANE WASHINGTON 99201
Phone	509.344.5900
Name of Person for Whose Account the Securities are To Be Sold	Bowden Steve M
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	8889	161253.35	16038337	11/28/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/01/2021	Restricted Stock Vesting	Issuer			490	10/01/2021	Compensation
Common	02/28/2023	Restricted Stock Vesting	Issuer			1622	02/28/2023	Compensation
Common	03/03/2023	Restricted Stock Vesting	Issuer			3313	03/03/2023	Compensation
Common	03/04/2024	Restricted Stock Vesting	Issuer			2305	03/04/2024	Compensation
Common	03/15/2024	Restricted Stock Vesting	Issuer			1159	03/15/2024	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	11/28/2025
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/29/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Jared Cook, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Steve M. Bowden
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)